Fibronectin gene polymorphism in patients with lung cancer

Oncology Reports

Volumn 8, Issue 6, 2001, Pages 1289-1292

  Siemianowicz, Krzysztof ^a   Gminski, Jan ^a   Francuz, Tomasz ^a   Syzdol, Marcin ^a   Polanska, Dorota ^a   Machalski, Marek ^a   Brulinski, Krzysztof ^b   Magiera Molendowska, Helena ^c  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Silesian Hospital of Tuberculosis and Lung Diseases   (Poland)

^c Pulmonological Ward of Municipal Hospital No 6 Katowice   (Poland)

Author keywords

Fibronectin; Lung cancer; Restriction fragment length polymorphisms

Indexed keywords

FIBRONECTIN;

ARTICLE; FEMALE; GENETICS; GENOTYPE; HUMAN; LUNG TUMOR; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; FEMALE; FIBRONECTINS; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0035511813     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.8.6.1289     Document Type: Article

References (36)

1. Bing DH, Almeda S, Isliker H, Lahav J and Hynes RO: Fibronectin binds to the Clq component of complement. Proc Natl Acad Sci USA 79: 4198-4201, 1979.
2. Bitterman PB, Rennard SI, Adelberg S and Crystal RG: Role of fibronectin as a growth factor for fibroblast. J Cell Biol 97: 1925-1932,1983.
3. Altunkova I, Minkova V and Belovezhdov N: Role of fibronectin in immune glomerulonephritis. Nephron 63: 438-444, 1993.
4. Kornblihtt AR, Pesce CG, Alonso CR, Cramer P, Srebrow A, Werbajh S and Muro AF: The fibronectin gene as a model for splicing and transcription studies. FASEB J 10: 248-257, 1996.
5. Gardella R, Colombi M and Barlati S: Human fibronectin gene (FN1) RFLPs: mapping and linkage disequilibrium analysis. Hum Genet 92: 639-641, 1993.
6. Colombi M. Gardella R, Barlati S and Vaheri A: A frequent HaeIII RFLP of the human fibronectin gene. Nucleic Acids Res 15:6761, 1987.
7. Gardella R, Colombi M and Barlati S: A common Mspl RFLP of the human fibronectin gene (FN1). Nucleic Acids Res 16: 1651, 1988.
8. Gardella R, Colombi M and Barlati S: A Taql RFLP of the human fibronectin (FN1) gene. Nucleic Acids Res 16: 11388, 1988.
9. Gardella R, Colombi M and Barlati S: A new Taql RFLP for the human fibronectin (FN1) gene. Nucleic Acids Res 17: 10520, 1989.
10. Avilla JJ, Lympany PA, Pantelidis P, Welsh KI, Black CM and du Bois RM: Fibronectin gene polymorphism associated with fibrosing alveolitis in systemic sclerosis. Am J Respir Cell Mol Biol 20: 106-112, 1999.
11. Rennard SI, Hunninghake GW, Bitterman PB and Crystal RG: Production of fibronectin by human alveolar macrophage: mechanism for the recruiment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci USA 78: 7147-7151, 1981.
12. Adachi K, Yamauchi K, Bernaudin JF, Fouret P, Ferrans VJ and Crystal RG: Evaluation of fibronectin gene expression by in situ hybridisation. Differential expression of the fibronectin gene among populations of human alveolar macrophages. Am J Pathol 133: 193-201, 1988.
13. Limper AH and Roman J: Fibronectin: a versatile matrix protein with roles in thoracic development, repair and infection. Chest 101: 1663-1773, 1992.
14. Armstrong PB and Armstrong MT: Intercellular invasion and organizational stability of tissues: a role for fibronectin. Biochim Biophys Acta 1470: 9-20, 2000.
15. Keil-Dlouha V, Planchenault T, Imhoff JM, Emod I, Blondeau X and Lambert-Vidmar S: Potentiel proteolytique de la fibronectine et degradation de la matrice extracellulare. Pathol Biol 38: 993-998, 1990.
16. Gold LI, Rostagno A. Frangione B and Passalaris T: Localization of the cleavage sites on fibronectin following digestion by urokinase. J Cell Biochem 50: 441-452, 1992.
17. Gminski J, Mykaba-Ciesla J, Machalski M and Drozd M: Elastin metabolism parameters in sera of patients with lung cancer. Neoplasma40: 41-44, 1993.
18. Gminski J, Mykala-Ciesla J, Machalski M and Drozdz M: Antielastin antibodies in patients with lung cancer. Immunol Lett 33: 211-215, 1992.
19. Ohnishi T, Hiraga S, Izumoto S, Matsumura H, Kanemura Y, Arita N and Hayakawa T: Role of fibronectin-stimulated tumor cell migration in glioma invasion in vivo: clinical significance of fibronectin and fibronectin receptor expressed in human glioma tissues. Clin Exp Metastasis 16: 729-741, 1998.
20. Ohnishi T, Arita N, Hiraga S, Taki T, Izumoto S, Fukushima Y and Hayakawa T: Fibronectin-mediated cell migration promotes glioma cell invasion through chemokinetic activity. Clin Exp Metastasis 15: 538-546, 1997.
21. Enam SA, Rosenblum ML and Edvardsen K: Role of extracellular matrix in tumor invasion: migration of glioma cells along fibronectin-possitive mesenchymal cell processes. Neurosurgery 42: 599-607, 1998.
22. Lohi J, Tani T, Laitinen L, Kangas L, Lehto VP and Virtanen I: Tenascin and fibronectin isoforms in human renal cell carcinomas, renal cell carcinoma cell lines and xenografts in nude mice. Int J Cancer 63:442-449, 1995.
23. Kochcvar GJ, Stanek JA and Ruckcr EB: Truncated fibronectin. Cancer 69: 2311-2115, 1992.
24. r 190,000-receptor protein. Blood 69: 578-583, 1987.
25. Hidalgo A, Sanz-Rodriguez F, Rodriguez-Fernandez JL, et al: Chemokine stromal cell-derived factor-1 alpha modulates VLA-4 integrin dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells. Exp Hematol 29: 345-355, 2001.
26. Sugahara H, Kanakura Y, Furitsu T, et al: Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5. J Exp Med 179: 1757-1766, 1994.
27. Van Riet I, de Greef C, del Favero H, Demanet C and van Camp B: Production of fibronectin by human myeloma cell lines. Br J Hematol 87: 258-265, 1994.
28. Moromoto M and Irimura T: Fibroblast migratory factor derived from mouse colon carcinoma cells: potential roles of fibronectin in tumor stroma formation. J Cell Biochcm 80: 635-646, 2001.
29. Moro L, Colombi M, Molinari Tosatti MP and Barlati S: Study of fibronectin and mRNA in human laryngeal and ectocervical carcinomas by in situ hybridization and image analysis. Int J Cancer 51: 692-697, 1992.
30. Gorogh T, Maune S, Lippert BM, et al: Trancriptional repression of the human fibronectin gene in laryngeal squamous cell carcinoma cells. J Cancer Res Clin Oncol 127: 166-172, 2001.
31. Zidar N, Gale N, Kambic V and Fischinger J: Expression of tenascin and fibronectin in benign epithelial hyperplastic lesions and squamous carcinoma of the larynx. Anticancer Res 21: 451-454, 2001.
32. Christensen L, Nielsen M, Andersen J and Clemmensen I: Stromal fibronectin staining pattern and metastasizing ability of human breast carcinoma. Cancer Res 48: 6227-6233, 1988.
33. Friedman R, Gelfand T, Weiss DW and Doljanski F: Patterns of fibronectin deposition in normal and neoplasmatic fibroblasts and mammary tissues. Int J Tissue React 6: 291-301, 1984.
34. Kirkali G, Tuzel E, Guler C, Cezer S and Kirkali Z: Significance of tissue laminin p(1) elastase and fibronectin levels in transitional cell carcinoma of the bladder. Eur Urol 39: 292-299, 2001.
35. Matsuura H and Hakomori S: The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6; its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc Natl Acad Sci USA 82: 6517-6521, 1985.
36. Wunderlich H, Reichelt O, Zermann DH, Schubert J, Berndt A and Kosmehl H: Fetal fibronectin: a new screening-marker for bladder cancer? Oncol Rep 8: 669-672, 2001.